Mapp Pharma’s ZMapp Appears to be Getting 30x the News Coverage as Tekmira’s TKM-Ebola

A couple of crude experiments this Saturday led me to reaffirm my short thesis on Tekmira Pharmaceuticals. Ending the week on little to no new news regarding the drug TKM-Ebola, Tekmira investors are being forced to wait until the WHO’s meeting Sept. 4-5 to hear more about the drug that they’re convinced is going to […]